Rating Change
HC Wainwright & Co. analysts reiterated a Buy rating on Precigen, Inc. (NASDAQ:PGEN) on August 05, 2026.
reiterateNASDAQ:PGEN
HC Wainwright & Co. Reiterates Buy Rating on Precigen, Inc. (PGEN)
Rating Change HC Wainwright & Co. analysts reiterated a Buy rating on Precigen, Inc. (NASDAQ:PGEN) on August 05, 2026.
Market Context
Precigen, Inc. operates in the Healthcare sector. The stock currently trades at $6.89 with a market capitalization of $1.1B. The stock has gained 266.5% over the past 52 weeks.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Precigen, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Precigen, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 05, 2026 | HC Wainwright & Co. | Buy | N/A |
| Aug 03, 2026 | HC Wainwright & Co. | Buy | N/A |
| May 28, 2026 | HC Wainwright & Co. | Buy | N/A |
| May 14, 2026 | Citizens | Market Outperform | N/A |
| May 14, 2026 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View PGEN Stock Page
Frequently Asked Questions
What does a Buy rating mean for PGEN?
A Buy rating from HC Wainwright & Co. reflects the analyst's outlook on Precigen, Inc. (NASDAQ:PGEN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PGEN forecast page.